Bharat Biotech presents Covaxin phase 3 trials data; Expert panel may have a meeting
The subject expert committee of the central drugs standards control organisation (CDSCO) will be reviewing the data of Covaxin’s phase 3 clinical trials cinducted by Bharat Biotech as the company submitted it to Drugs Controller General of India (DCGI) over the weekend, according to sources aware about the development. An official, who wants to be…